SEC Form 4 · accession 0001765581-19-000015
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Suzanne Sawochka Hooper
Officer — EVP & General Counsel
Period of report
Feb 25, 2019
Accepted (ET)
Feb 27, 2019 · 9:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Feb 25, 2019 | F | 783 | $126.25 | D | 40,401 | D | |
| Ordinary Shares | Feb 26, 2019 | F | 663 | $127.76 | D | 39,738 | D | |
| Ordinary Shares | Feb 27, 2019 | M | 6,666 | $46.83 | A | 46,404 | D | |
| Ordinary Shares | Feb 27, 2019 | S | 6,666 | $140.00 | D | 39,738 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F3 | $46.83 | Feb 27, 2019 | M | 6,666 | D | — | Aug 8, 2022 | Ordinary Shares | 6,666 | 28,671 | D |
Explanation of responses
- F1Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
- F2This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F3This non-qualified stock option is part of an option award granted on August 9, 2012. The ordinary shares subject to the option award vested over 4 years from the vesting commencement date of August 9, 2012, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments thereafter and were fully vested as of August 9, 2016.